Pine Pharmaceuticals, LLC recalls Bevacizumab 2.5 mg/0.1 mL in 3/10 mL 31 G 5/16" Syringe for intravitreal injection, Rx -- Pine Pharmaceuticals, 100 Col…
- Recall date
- November 4, 2015
- Source
- U.S. Food & Drug Administration (FDA) — enforcement report
- Recall number
- D-0584-2016
- FDA classification
- Class II
- Brand / firm
- Pine Pharmaceuticals, LLC
- Sold / distributed
- Nationwide and Puerto Rico
Why it was recalled
Presence of particulate matter: Presence of silicone oil microdroplets in bevacizumab syringes for intravitreal use.
Class II means using this product may cause temporary or medically reversible health problems; the chance of serious harm is remote.
What was recalled
Bevacizumab 2.5 mg/0.1 mL in 3/10 mL 31 G 5/16" Syringe for intravitreal injection, Rx -- Pine Pharmaceuticals, 100 Colvin Woods Pkwy Suite 300, Tonawanda, NY 14150.
Get recall alerts
Free email alert whenever Pine Pharmaceuticals, LLC has a new recall — straight from official government data. Unsubscribe anytime.
More recalls from: Pine Pharmaceuticals, LLC